Cell-Membrane-Coated Nanoreactors Rejuvenate Aging Bone Marrow Stem Cells in Mice

Deep inside every bone lies a factory that quietly rebuilds the skeleton throughout life. Its most important workers are a population of stem and progenitor cells marked by a protein called the leptin receptor, known as LepR-positive cells. These cells generate most of the bone formed by adult marrow and secrete factors that nurture blood vessels, lymphatic vessels, and nerves within the marrow cavity. With age, however, these vital cells fall into a state of senescence: they stop dividing efficiently, lose their bone-forming capacity, and poison their surroundings with inflammatory signals. The result is a marrow that gradually trades bone for fat, a hallmark of skeletal aging that contributes to osteoporosis and frailty in millions of older adults worldwide.

A research team led by Ke Li and colleagues at institutions in China has now deciphered a self-reinforcing molecular circuit that drives this decline, and has built a tiny biomimetic machine to break it. Writing in the journal Materials Today Bio, the researchers describe a nanoreactor called CLPM that simultaneously delivers nitric oxide and magnesium ions into senescent LepR-positive cells while scavenging the reactive oxygen species that accumulate inside them. In aged mice, a single course of local treatment restored youthful gene expression patterns, reversed measurable bone loss, and even stimulated the regeneration of vascular, lymphatic, and neural components of the marrow niche. The work offers a striking example of how precision nanomedicine might one day rejuvenate not just individual cells but entire aging tissues.

The team began by mining gene expression data from young and aged mouse bone marrow. Principal component analysis and gene set enrichment analysis revealed that aged LepR-positive cells were strongly enriched for senescence programs, and that three interconnected pathways had shifted in a coordinated fashion: nitric oxide biosynthesis was downregulated, magnesium ion homeostasis was impaired, and reactive oxygen species metabolism was upregulated. Immunofluorescence staining of aged marrow sections confirmed the shift at the cellular level, showing a marked increase in the proportion of LepR-positive cells expressing P21, a canonical senescence marker, and IL-6, a pro-inflammatory cytokine released by senescent cells.

The connection between these three pathways forms the core of the team’s mechanistic insight. Nitric oxide is a gaseous signaling molecule that regulates vasodilation, neurotransmission, and stem cell fate, and its production declines progressively with age. Nitric oxide signaling is closely linked to intracellular magnesium concentration, because the gas modulates the activity of magnesium transporters through cGMP-dependent and calcium-mediated mechanisms. When nitric oxide production falls, magnesium influx into the cell falls with it. Magnesium deficiency, in turn, promotes electron leakage from the mitochondrial respiratory chain, which drives excessive production of reactive oxygen species. The accumulated ROS then push the cell further into senescence, and senescent cells produce even less nitric oxide and take up even less magnesium. The researchers describe this as a vicious cycle of aging, decreased nitric oxide and magnesium, accumulated ROS, and further aging, and their data suggest it operates in aged LepR-positive cells in the bone marrow.

To disrupt the cycle, the team constructed a nanoparticle system with three complementary functions packed into a single platform roughly 115 nanometers in diameter. The core is made of a block copolymer called mPEG-b-PPS, loaded with L-arginine that has been converted into a hydrophobic ion pair with oleate. L-arginine serves as a substrate for endogenous nitric oxide synthase enzymes, allowing the cell to generate its own nitric oxide once the cargo is released. Magnesium ions were then introduced to coordinate with the carboxylate groups of the L-arginine-oleate complex, forming multivalent crosslinks that stabilize the nanoparticle core. Finally, the researchers isolated cell membrane vesicles from senescent LepR-positive cells and coated them onto the core by extrusion, creating a biomimetic shell that exploits homologous targeting: the membrane carries the same surface markers as the target cells, encouraging uptake while helping the particles evade immune surveillance.

The design has a built-in trigger that makes the particles respond specifically to the aged intracellular environment. The PPS block contains oxidation-sensitive thioether groups. When senescent cells take up the particles, the elevated reactive oxygen species inside them oxidize the hydrophobic sulfide groups into more hydrophilic sulfoxide and sulfone groups. This hydrophobic-to-hydrophilic transition destabilizes the nanoparticle core and promotes its disassembly, and because ROS are consumed during the oxidation, the process simultaneously neutralizes the very molecules that triggered it. Disassembly of the core weakens the magnesium-carboxylate coordination network, facilitating intracellular magnesium release, while the freed L-arginine becomes available for conversion into nitric oxide. In effect, the aged cell’s own oxidative stress acts as the switch that activates the therapy.

Physicochemical characterization confirmed the construction. Transmission electron microscopy showed well-dispersed spherical particles with mean diameters of 98.2 nanometers for the uncoated core and 114.7 nanometers for the membrane-coated version. Zeta potential measurements shifted from 4.3 millivolts for the core to -12.6 millivolts after coating, consistent with the addition of the cell membrane, and immunofluorescence staining showed substantial colocalization of LepR and membrane markers on the final particles. Fourier-transform infrared spectroscopy revealed shifts in the carboxylate stretching peaks upon magnesium coordination, and X-ray photoelectron spectroscopy detected a characteristic magnesium signal at approximately 1303 electron volts, verifying successful incorporation of the metal ions. Elemental mapping demonstrated homogeneous magnesium distribution throughout the core.

Functional assays in cultured cells demonstrated that the nanoreactor works as intended. Senescent LepR-positive cells treated with the membrane-coated particles showed a time-dependent increase in uptake compared with uncoated particles, confirming the targeting advantage. Intracellular nitric oxide levels rose, magnesium concentrations increased, and accumulated reactive oxygen species were effectively eliminated. Senescence-associated beta-galactosidase staining, a standard measure of cellular aging, showed a marked reduction in senescent cells after treatment. The cells also shifted their differentiation commitment: alkaline phosphatase and alizarin red staining indicated a pronounced bias toward osteogenic, or bone-forming, differentiation, while Oil Red O staining showed reduced lipid droplet formation. Gene expression analysis confirmed the shift, with downregulation of the senescence marker P21 and the adipogenic genes PPARγ and FABP4, alongside restoration of the osteogenic genes OSX and OCN.

In aged mice, local administration of the nanoreactor produced measurable remodeling of the bone marrow. Micro-computed tomography of the femurs revealed significantly increased bone volume fraction, trabecular number, and trabecular thickness, along with decreased trabecular separation, indicating new bone formation. Histological examination showed reduced proportions of P21-positive cells and fewer marrow adipocytes. Markers of vascular, lymphatic, and neural regeneration, including CD31, VEGF-C, LYVE1, NGF, and TUBB3, were all elevated in the treated marrow, suggesting that rejuvenating the LepR-positive population had ripple effects throughout the niche. H&E staining of major organs revealed no apparent histopathological abnormalities, though the authors note that systemic pharmacokinetics, biodistribution, immunogenicity, and long-term safety remain to be investigated.

To confirm that the therapy works by breaking the vicious cycle rather than through some unrelated mechanism, the team performed RNA sequencing on treated cells and found that cellular senescence, cell cycle, and p53 signaling pathways were significantly altered. In vivo nitric oxide probes injected into the marrow cavity confirmed elevated nitric oxide production in treated animals, and inductively coupled plasma analysis of cell lysates showed substantially higher magnesium levels. Critically, when the researchers added a nitric oxide inhibitor, a magnesium-depleting agent, or a ROS activator to cells isolated from treated mice, the senescent phenotype returned, with increased proportions of senescence-associated beta-galactosidase and P21-positive cells. This loss-of-function experiment provides direct evidence that the anti-aging effect depends on the nitric oxide, magnesium, and ROS axis. The authors acknowledge that the optimal therapeutic dosage may vary with the severity of senescence, and they suggest that integrating imaging modalities such as MRI, PET, and fluorescence imaging to enable spatiotemporally controlled release will be important for next-generation anti-aging nanomedicines. Validation in broader aging models and large-animal studies will be required before clinical translation, but the work establishes a compelling proof of concept that breaking a single molecular circuit in a key stem cell population can remodel an entire aging tissue.

Subject of Research: Aging and Regenerative Medicine

Article Title: Aged microenvironment-triggered nanoreactors rejuvenate senescent LepR + cells to remodel aged bone marrow

Article References: Li, K., Li, Z., Xue, Y., Liu, H., Guo, J., Zhang, X., Li, B., & Rui, Y. (2026). Aged microenvironment-triggered nanoreactors rejuvenate senescent LepR+ cells to remodel aged bone marrow. Materials Today Bio, 41, Article 103751. https://doi.org/10.1016/j.mtbio.2026.103751

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103751

Keywords: aging, nanomedicine, bone marrow, stem cells, senescence, nanotechnology, Aged, microenvironment-triggered, nanoreactors, rejuvenate, senescent, LepR